Category: Top Story

  • InMode Shares Gain After Preliminary Q3 Revenue Beats Expectations

    InMode Shares Gain After Preliminary Q3 Revenue Beats Expectations

    Shares of InMode Ltd. (NASDAQ:INMD) climbed 9% on Thursday after the medical technology company released preliminary third-quarter revenue figures that came in well above Wall Street forecasts, while also reaffirming its full-year outlook. InMode reported preliminary Q3 revenue between $92.5 million and $93.0 million, topping the consensus estimate of $87.9 million, representing a beat of…

  • Momentus Shares Jump After Winning $5.1 Million NASA Contract

    Momentus Shares Jump After Winning $5.1 Million NASA Contract

    Shares of Momentus Inc. (NASDAQ:MNTS) climbed 10.6% in premarket trading on Thursday after the commercial space transportation company announced it had secured a $5.1 million contract from NASA under its Flight Opportunities program. The contract, awarded on September 26, will support the Commercial Orbital System for Microgravity In-Space Crystallization (COSMIC) demonstration. Momentus will use its…

  • Bluejay Diagnostics Shares Skyrocket After Strengthening Manufacturing Deal with SanyoSeiko

    Bluejay Diagnostics Shares Skyrocket After Strengthening Manufacturing Deal with SanyoSeiko

    Shares of Bluejay Diagnostics Inc (NASDAQ:BJDX) surged 110% in premarket trading on Thursday after the medical diagnostics firm announced it had expanded its manufacturing partnership with SanyoSeiko Co., Ltd. of Japan. The company, which develops rapid testing solutions for near-patient diagnostics, said it had amended its Master Service and Master Supply Agreements with SanyoSeiko to…

  • Alterity Therapeutics Shares Edge Higher After Encouraging MSA Trial Results

    Alterity Therapeutics Shares Edge Higher After Encouraging MSA Trial Results

    Shares of Alterity Therapeutics Ltd (NASDAQ:ATHE) climbed 3.3% in premarket trading on Thursday after the company unveiled promising clinical data from its Phase 2 trial for Multiple System Atrophy (MSA) during a key medical conference. The biotech firm shared the results of its ATH434-201 randomized, double-blind study at the International Congress of Parkinson’s Disease and…

  • Klarna Shares Climb on New AI Partnership with Google Cloud

    Klarna Shares Climb on New AI Partnership with Google Cloud

    Shares of Klarna (NYSE:KLAR) rose 3% on Thursday after the fintech company announced a strategic collaboration with Google Cloud aimed at accelerating the integration of artificial intelligence across its global payments and shopping platform, which serves more than 114 million users. Under the agreement, Klarna will harness Google Cloud’s advanced AI infrastructure to develop innovative…

  • Medirom Shares Surge After Subsidiary Greenlights Private Placement

    Medirom Shares Surge After Subsidiary Greenlights Private Placement

    Shares of Medirom Healthcare Technologies Inc. (NASDAQ:MRM) jumped 22% in premarket trading on Thursday after its health tech subsidiary, MOTHER Labs, approved a private placement of new shares to two senior executives. The private placement is part of MOTHER Labs’ Series A funding round and assigns the subsidiary a valuation of approximately 9 billion yen…

  • Central Bank Gold Buying Doubles Long-Term Average, Pushing Prices to Historic Highs

    Central Bank Gold Buying Doubles Long-Term Average, Pushing Prices to Historic Highs

    Gold prices climbed past $4,000 per ounce this week, reaching inflation-adjusted levels not seen since 1980, as a surge in central bank demand drives the latest rally in the precious metal. According to strategists at Deutsche Bank, official sector purchases are currently running at twice the pace of the 2011–2021 average, with China at the…

  • Novo Nordisk expands its liver disease portfolio with the acquisition of Akero Therapeutics for up to $5.2 billion

    Novo Nordisk expands its liver disease portfolio with the acquisition of Akero Therapeutics for up to $5.2 billion

    Novo Nordisk (NYSE:NVO) announced the acquisition of U.S.-based Akero Therapeutics (NASDAQ:AKRO) for up to $5.2 billion, expanding its presence in the treatment of liver diseases associated with obesity. The deal marks the first major transaction under new CEO Maziar Mike Doustdar. The Danish pharmaceutical company will pay $54 per share, totaling approximately $4.7 billion, a…

  • Dow Jones, S&P, Nasdaq, Futures, Wall Street seen opening flat as traders digest Wednesday’s gains

    Dow Jones, S&P, Nasdaq, Futures, Wall Street seen opening flat as traders digest Wednesday’s gains

    U.S. stock futures pointed to a quiet open on Thursday, with investors showing caution after markets rallied to new record highs in the previous session. With the federal government shutdown stretching into its ninth day, the release of several key economic reports — including the weekly jobless claims figures — has been postponed. The lack…

  • Google launches Gemini Enterprise, a new AI platform for businesses

    Google launches Gemini Enterprise, a new AI platform for businesses

    Google (NASDAQ:GOOG) unveiled Gemini Enterprise on Thursday — a powerful new artificial intelligence platform aimed at transforming workplace productivity by integrating company data, workflows, and employees into one centralized interface. Described as “the new front door for AI in the workplace,” the platform is powered by Google’s most advanced Gemini models and offers employees a…